Magic mushroom compound could help treat anorexia in young adults
NCT ID NCT07169747
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study tests whether psilocybin, a psychedelic substance, given with psychological support is safe and helps reduce symptoms of anorexia nervosa in young adults aged 16 to 35. Participants receive two doses of psilocybin (25 mg) four weeks apart, plus therapy before, during, and after. The study compares this to standard care and tracks side effects, symptom changes, and brain scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANOREXIA NERVOSA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Psykiatrikliniken, Baravägen 1
RECRUITINGLund, 22240, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a parent support group help teens with both autism and anorexia?
- Lab-Grown brain cells could unlock Anorexia's secrets
- Can science unlock the secrets of the naturally lean?
- Can a memory drug break the grip of Anorexia's rigid habits?
- A digital lifeline for caregivers: can a 12-Week online program ease the strain of supporting a teen with anorexia?
- 3D infrared scans may reveal hidden malnutrition in anorexia — a study puts the idea to the test